One of the most exploited mechanisms by tumors involves immune checkpoints, such as PD-L1 (programmed death-ligand 1) and CTLA-4 (cytotoxic T-lymphocyte associated protein 4), which inhibit T-cell activation, allowing cancer cells to escape immune-mediated destruction [8]. Here, CTLA4 is linked to cancer.